From Molecules to Machines: An Integrative Framework Linking Molecular Pathogenesis, Multi‐Factorial Risk, Risk Stratification, Clinical Management, and Artificial Intelligence in QT Prolongation and Sudden Cardiac Death
Open Access
- 11 June 2026
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 49 (6) , e70370
Abstract
QT prolongation causes torsades de pointes sudden death from heritable, pharmacologic, metabolic, nutritional triggers. Its dimensions have been studied separately. This integrative review synthesizes research on molecular pathogenesis, acquired/metabolic/nutritional risks, clinical stratification, therapy, and AI prediction. Dual‐function channel mutations and post‐translational defects underlie congenital LQTS beyond classic three genes. Drug–gene–metabolic interactions amplify acquired risk; insulin resistance, NAFLD, and adiposity are independent risk factors. Nutritional exposures (grapefruit juice, licorice, energy drinks) compound arrhythmic risk. QTc threshold alone is insufficient; T‐wave morphology, genotype, electromechanical window dynamics, and M‐FACT score add prognostic value. Nonpenetrant LQTS carries near‐population‐level event risk. Genotype‐targeted mexiletine and left cardiac sympathetic denervation are validated alternatives. Machine learning outperforms clinical scores; deep learning distinguishes congenital from acquired QT prolongation on ECG. Precision QT management requires integrated strategies including nutritional and metabolic determinants, QTc measurement, and AI‐enhanced prediction. Prospective data remain essential before algorithmic tools guide decisions.Keywords
This publication has 81 references indexed in Scilit:
- QT Assessment in Early Drug Development: The Long and the Short of ItInternational Journal of Molecular Sciences, 2019
- High-performance medicine: the convergence of human and artificial intelligenceNature Medicine, 2019
- Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural networkNature Medicine, 2019
- The genetic architecture of long QT syndrome: A critical reappraisalTrends in Cardiovascular Medicine, 2018
- Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc IntervalCirculation: Arrhythmia and Electrophysiology, 2018
- Clinical Spectrum of SCN5A MutationsJACC: Clinical Electrophysiology, 2018
- Contemporary Outcomes in Patients With Long QT SyndromeJACC, 2017
- A Prospective Study of Sudden Cardiac Death among Children and Young AdultsNew England Journal of Medicine, 2016
- Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3JACC, 2016
- Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT IntervalsJACC, 2011